Eu Ivdd Eu Ivd General On The Market 🇨🇳 China

TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER

Amoy Diagnostics Co., LTD. · 🇨🇳 China
Devices (same UDI-DI)
1
Certificates
0
Countries
0
Notified Bodies
0

Basic Information

Primary DI
06959094210809
Basic UDI-DI Code
B-06959094210809
Reference
8.01.0246
Device Types
None provided
Regulation
Eu Ivdd
Classification
Eu Ivd General
Status
On The Market

Additional Description

The AmoyDx ® Pan Lung Cancer PCR Panel is a real-time PCR assay for qualitative detection of 167 hotspot alterations in EGFR, ALK, ROS1, KRAS, BRAF, HER2, RET, MET, NTRK1, NTRK2 and NTRK3 genes. The kit is intended to be used to aid clinician to identify multi- gene status for NSCLC patients. The kit is for in vitro diagnostic use, and intended to be used by trained professionals in a laboratory environment.

CND Nomenclature Codes

Code Description
W01060299 TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).

View all